Predicting Progression of Developing Myeloma in a High Risk-Screened Population (PROMISE)

R
Rafat Abonour, MD

Primary Investigator

Predicting Progression of Developing Myeloma in a High Risk-Screened Population (PROMISE)

Overview

We will further study people who test positive for these early warning signs of multiple myeloma so that we can learn how to prevent them from developing into cancer. 
 
Your participation may help researchers find new ways to prevent and treat blood cancer.
 

Description

 
Please take our survey to see if you qualify: PROMISE Eligibility Questionnaire 
 
This study aims to find new ways to prevent and treat blood cancer.

Your participation may help prevent multiple myeloma in future generations.

For more information, please visit the PROMISE study website: https://www.enroll.promisestudy.org/

Eligibility

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    healthy
  • Age: Between 40 Years - 75 Years
  • Gender: All

Inclusion criteria
  • People who may have higher risks, but have not been diagnosed with multiple myeloma, another blood cancer, or related conditions

Updated on 09 Mar 2024. Study ID: 18-370

Connect with a study center near you

What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center